SISB INVESTMENT ADVISERS (UK) LTD

Institutional investor · Portfolio as of Q1 2026

SEC EDGAR SourceSEC Filings

Top Holdings10 positions

Export CSV(Pro)
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
CPNGCPNG

COUPANG INC

289.5M$5.5B70.7%$48.75-61.44%
21 qtrssince 2021-Q1
Unchanged
0
GRABGRAB

GRAB HOLDINGS LIMITED

401.8M$1.5B19.0%$7.08-44.53%
18 qtrssince 2021-Q4
Unchanged
0
RLAYRLAY

RELAY THERAPEUTICS INC

27.9M$277.7M3.6%$39.98-49.97%
23 qtrssince 2020-Q3
Unchanged
0
COMPCOMP

COMPASS INC

22M$160.9M2.1%$13.50-13.19%
20 qtrssince 2021-Q2
Decreased
0
VIRVIR

VIR BIOTECHNOLOGY INC

10.9M$98.1M1.3%$12.12-17.82%
26 qtrssince 2019-Q4
Decreased
0
AURAUR

AURORA INNOVATION INC

19.8M$81.6M1.1%$11.41-44.08%
18 qtrssince 2021-Q4
Unchanged
0
ROIVROIV

ROIVANT SCIENCES LTD

2.7M$74M1.0%$10.64+238.06%
18 qtrssince 2021-Q4
Decreased
0
NRGVNRGV

ENERGY VAULT HOLDINGS INC

15.5M$51.3M0.7%$9.89-65.22%
16 qtrssince 2022-Q2
Decreased
0
YMMYMM
ADR

FULL TRUCK ALLIANCE CO LTD

5.3M$43.8M0.6%$12.11-29.25%
15 qtrssince 2022-Q3
Unchanged
0
DNADNA

GINKGO BIOWORKS HOLDINGS INC

610,729$3.7M0.0%$67.60-86.55%
14 qtrssince 2022-Q4
Unchanged
0
$7.7B
AUM
10
Positions
Q1 2026
Filing
Rating · 1.5
Quarterly Portfolio Change
-6%Q4'24$11.4B-4%Q1'25$11B+15%Q2'25$12.6B+5%Q3'25$13.3B-25%Q4'25$10B-23%Q1'26$7.7B
Activity profile
$ moved · Q1'26
New0%Increased0%Decreased100%Exited0%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 4.5 years
<1Q0%1-4Q0%1-2Y0%2Y+100%

SB INVESTMENT ADVISERS (UK) LTD manages $7.7B across 10 positions as of Q1 2026. Top holdings: CPNG (70.7%), GRAB (19.0%), RLAY (3.6%). Fund DNA: Concentrated Value. HoldingsIntel Rating: 1.5/5.0.

Q1 2026 Summary

Trimmed 4. No standout high-conviction moves this quarter. Portfolio: $7.7B across 10 positions.

Portfolio Allocation

Top holdings by portfolio weight

Total AUM$8B
CPNG70.74%
GRAB19.03%
RLAY3.59%
COMP2.08%
VIR1.27%
AUR1.06%
ROIV0.96%
NRGV0.66%
YMM0.57%
DNA0.05%
Sector Breakdown

Portfolio allocation by GICS sector

Sectors5
Consumer Cyclical70.74%
Technology20.65%
Healthcare5.87%
Real Estate2.08%
Utilities0.66%
Fund DNA

Behavioral investing profile

Concentrated Value83%- primarily Consumer Cyclical, Technology
Compare DNA across all funds
Fund Rating
7-dimension quality assessment
Below Average(1.5 / 5.0)
Track Record14
Conviction37
Concentration100
Upgrade to see all dimensions

Position Outcomes

Best and worst performing positions by estimated return

Top Losers

Upgrade to Pro to see the worst-performing positions.

View plans

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

ICAHN CARL C
$8.6B
Independent Franchise Partners LLP
$14.3B
+3 more

Explore More

Compare SB INVESTMENT ADVISERS…
Side-by-side holdings comparison
High-Conviction Picks
Top conviction positions this quarter
Double-Down Detection
Buying into price weakness
Best Trades
Top performing positions by P&L
All Concentrated Value Funds
Investing archetypes and behavior

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Continue exploring

Explore high-conviction positions
See which stocks have the strongest institutional commitment
Compare with similar funds
Find portfolio overlap with SB INVESTMENT ADVISERS (U…
Clone this fund
Backtest what copying SB INVESTMENT ADVISERS (U…'s portfolio would return

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used